Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Curcumin × CNS × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17 Genitourinary 10 Breast 9 Gynecologic 6 Plasma cell 5 Thoracic 3 Lymphoid 3 Other hematologic neoplasm 2 Other 1 Myeloid 1 Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Neurofibromatosis 1 1

Interventions

Temozolomide 521 Radiotherapy 332 Bevacizumab 216 Magnetic Resonance Spectroscopy 175 Cyclophosphamide 148 Carboplatin 135 Radiosurgery 132 Etoposide 110 Radiation 100 Irinotecan 99 Vincristine 93 Cisplatin 82 Filgrastim 81 pembrolizumab 74 Specimen Handling 74 Lomustine 73 Nivolumab 71 Surgical Procedures, Operative 59 Topotecan 57 Melphalan 51 Carmustine 50 Radiotherapy, Intensity-Modulated 45 Doxorubicin 45 sargramostim 44 Peripheral Blood Stem Cell Transplantation 44 Granulocyte Colony-Stimulating Factor 44 Isotretinoin 42 Chemotherapy, Adjuvant 41 Erlotinib Hydrochloride 40 Granulocyte-Macrophage Colony-Stimulating Factor 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05363267 2026-01-13

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡